The chemical class termed Stereocilin, STRC, Activators encompasses a range of compounds that interact with cellular pathways and structural components to influence the function of the STRC protein. These activators are not direct ligands of stereocilin but act upon the broader cellular environment and the intricate network of processes that sustain the mechanosensory function of the inner ear. Their modes of action involve modulation of actin dynamics, alteration of intracellular signaling, and regulation of protein transport. By targeting the cytoskeleton, certain members of this class can enhance the stability and maintenance of stereocilia, which are essential for the transduction of auditory signals. The stability of F-actin, which forms the core of stereocilia, is pivotal in preserving their structure and function; thus, any agent that stabilizes actin filaments indirectly supports the role of stereocilin within these sensory cells.
Other members of the STRC Activators class operate by modulating key enzymes and molecular pathways that govern the motility and tension of stereocilia, which are vital for their responsiveness to mechanical stimuli. By influencing kinase activity or calcium signaling, these compounds can affect the hair cell's electrophysiological properties and its ability to convert sound waves into electrical impulses. Additionally, some chemicals in this group impact the protein transport mechanisms that are essential for the correct localization and function of STRC within the hair cells. By indirectly orchestrating the cellular milieu in which stereocilin operates, STRC Activators facilitate the functional expression of this protein, which plays a crucial role in hearing. It is through the delicate balance of these cellular processes that STRC activators can exert their influence, ensuring the optimal performance of stereocilin and the maintenance of auditory function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the ADP-ribosylation factor, which could possibly activate STRC through effects on its transport or localization. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and could possibly activate STRC by enhancing the structural integrity of stereocilia. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Inhibits actin polymerization, which could possibly activate STRC by altering cytoskeletal dynamics and associated pathways. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Binds and stabilizes F-actin, which could possibly activate STRC by supporting the maintenance of stereocilia structure. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Disrupts microfilaments by binding to actin monomers, which could possibly activate STRC by influencing cytoskeletal organization. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibitor of ROCK kinase, which could possibly activate STRC by altering the tension within stereocilia. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibits myosin II, which could possibly activate STRC by affecting the tension and movement of stereocilia. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase and increases cAMP, which could possibly activate STRC through effects on cellular signaling pathways. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist; could possibly activate STRC by altering calcium signaling within hair cells. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, which could possibly activate STRC by influencing the motility and structure of stereocilia. | ||||||